0001104659-23-070395.txt : 20230612
0001104659-23-070395.hdr.sgml : 20230612
20230612164849
ACCESSION NUMBER: 0001104659-23-070395
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230608
FILED AS OF DATE: 20230612
DATE AS OF CHANGE: 20230612
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: WAGENHEIM PHILIP
CENTRAL INDEX KEY: 0001405684
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39580
FILM NUMBER: 231008785
MAIL ADDRESS:
STREET 1: 712 FIFTH AVENUE
STREET 2: 49TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10019
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Immunome Inc.
CENTRAL INDEX KEY: 0001472012
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 770694340
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 665 STOCKTON DRIVE
STREET 2: SUITE 300
CITY: EXTON
STATE: PA
ZIP: 19341
BUSINESS PHONE: 610-321-3700
MAIL ADDRESS:
STREET 1: 665 STOCKTON DRIVE
STREET 2: SUITE 300
CITY: EXTON
STATE: PA
ZIP: 19341
4
1
tm2318426d2_4seq1.xml
OWNERSHIP DOCUMENT
X0407
4
2023-06-08
0
0001472012
Immunome Inc.
IMNM
0001405684
WAGENHEIM PHILIP
C/O IMMUNOME, INC.
665 STOCKTON DRIVE, SUITE 300
EXTON
PA
19341
1
0
0
0
0
Stock Option (Right to Buy)
4.84
2023-06-08
4
A
0
6500
0
A
2033-06-08
Common Stock
6500
6500
D
The shares subject to the options shall vest 25% every quarter after the grant date.
/s/ Purnanand D. Sarma, Attorney-in-Fact
2023-06-12